Effects of bilateral sequential theta-burst stimulation on 5-HT<sub>1A</sub> receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial

Author(s)
Matej Murgaš, Jakob Unterholzner, Peter Stöhrmann, Cécile Philippe, Godber M. Godbersen, Lukas Nics, Murray B. Reed, Chrysoula Vraka, Thomas Vanicek, Wolfgang Wadsak, Georg S. Kranz, Andreas Hahn, Markus Mitterhauser, Marcus Hacker, Siegfried Kasper, Rupert Lanzenberger
Abstract

Theta-burst stimulation (TBS) represents a brain stimulation technique effective for treatment-resistant depression (TRD) as underlined by meta-analyses. While the methodology undergoes constant refinement, bilateral stimulation of the dorsolateral prefrontal cortex (DLPFC) appears promising to restore left DLPFC hypoactivity and right hyperactivity found in depression. The post-synaptic inhibitory serotonin-1A (5-HT1A) receptor, also occurring in the DLPFC, might be involved in this mechanism of action. To test this hypothesis, we performed PET-imaging using the tracer [carbonyl-11C]WAY-100635 including arterial blood sampling before and after a three-week treatment with TBS in 11 TRD patients compared to sham stimulation (n = 8 and n = 3, respectively). Treatment groups were randomly assigned, and TBS protocol consisted of excitatory intermittent TBS to the left and inhibitory continuous TBS to the right DLPFC. A linear mixed model including group, hemisphere, time, and Hamilton Rating Scale for Depression (HAMD) score revealed a 3-way interaction effect of group, time, and HAMD on specific distribution volume (VS) of 5-HT1A receptor. While post-hoc comparisons showed no significant changes of 5-HT1A receptor VS in either group, higher 5-HT1A receptor VS after treatment correlated with greater difference in HAMD (r = −0.62). The results of this proof-of-concept trial hint towards potential effects of TBS on the distribution of the 5-HT1A receptor. Due to the small sample size, all results must, however, be regarded with caution.

Organisation(s)
Department of Inorganic Chemistry
External organisation(s)
Medizinische Universität Wien, Hong Kong Polytechnic University, Ludwig Boltzmann Intitute Applied Diagnostics
Journal
Translational Psychiatry
Volume
13
ISSN
2158-3188
DOI
https://doi.org/10.1038/s41398-023-02319-3
Publication date
12-2023
Peer reviewed
Yes
Austrian Fields of Science 2012
302065 Clinical psychiatry, 301210 Psychopharmacology
ASJC Scopus subject areas
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Biological Psychiatry
Sustainable Development Goals
SDG 3 - Good Health and Well-being
Portal url
https://ucrisportal.univie.ac.at/en/publications/649e80f0-c27b-48fd-b5ac-2e888cbdaf46